Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peanut Dissolving Film is a sublingual orally dissolving film being developed by Johns Hopkins School of Medicine for the treatment of peanut allergy. The active ingredient is peanut extract, which contains the major peanut allergen Ara h 2. This product is a form of allergen immunotherapy designed to desensitize patients. It is administered as a film that dissolves quickly under the tongue to modulate the immune response, affecting peanut-specific IgE and IgG antibodies and basophil reactivity. The film formulation is based on water-soluble polymers like hydroxypropyl methylcellulose (HPMC).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on peanut dissolving film.